Mawdsleys Revenue and Competitors

Salford, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Mawdsleys's estimated annual revenue is currently $76M per year.(i)
  • Mawdsleys's estimated revenue per employee is $201,000

Employee Data

  • Mawdsleys has 378 Employees.(i)
  • Mawdsleys grew their employee count by 6% last year.

Mawdsleys's People

NameTitleEmail/Phone
1
Group CEOReveal Email/Phone
2
Head Hospital ServiceReveal Email/Phone
3
Quality Assurance OfficerReveal Email/Phone
4
Head Facilities and HSEReveal Email/Phone
5
Senior QA Officer & Responsible PersonReveal Email/Phone
6
Head Finance - BrazilReveal Email/Phone
7
Quality Assurance OfficerReveal Email/Phone
8
Head Compliance / Lead RP / RPiReveal Email/Phone
9
Head TransportReveal Email/Phone
10
Head Commercial OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$22.9M1144%£18MN/A
#2
$8.4M420%N/AN/A
#3
$69.7M34712%N/AN/A
#4
$234.1M7285%$5.7MN/A
#5
$165.2M8222%N/AN/A
#6
$19.3M967%N/AN/A
#7
$28.7M14317%N/AN/A
#8
$69.7M34721%N/AN/A
#9
$24.1M12025%N/AN/A
#10
$62.1M309N/AN/AN/A
Add Company

What Is Mawdsleys?

Mawdsleys are a UK based pharmaceutical wholesaler and leading partner to the healthcare sector and pharmaceutical industry. They offer a range of services:\n\nPharmaceutical Industry:-\nPharma Third Party Logistics (3PL)\nNamed Patient Medicine Distribution\nClinical Trial Logistics (inc. blinding, randomisation, labelling, global distribution)\nClinical Trial Materials sourcing & manufacture (inc. IMPs, placebos, over encapsulation)\nRegulatory Affairs Services (inc. QP Release / batch certification, QP Services, RP Services)\nPatient Information Testing\n\nHealthcare Sector:-\nWholesale Services to hospitals\nInternational Sales\nUnlicensed / Named Patient Medicine Supply\nClinical Trial Supply to hospitals and academia (inc. placebos)\nPharmaceutical Overlabelling\nPharmacy IT systems

keywords:N/A

N/A

Total Funding

378

Number of Employees

$76M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Mawdsleys News

2022-02-22 - Company led medicines recall: Bucain Hyperbar 5mg/ml Solution for ...

Mawdsley-Brooks & Company Limited (UK importer) is recalling the above ... please contact Charlotte Ray: charlotte.ray mawdsleys.co.uk.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$64.5M4303%N/A
#2
$327.6M709N/AN/A
#3
$120.8M71931%N/A
#4
$438.1M1079N/AN/A
#5
$315.5M12957%N/A